Chemiluminescence Immunoassay CLIA Analyzers Market

Company Headquarters: Saluggia, Italy Founded: 2000 Workforce: ~ 1,971 Company Working: DIASORIN S.P.A. is an Italian multinational group and a global leader in the in-vitro diagnostics market. It is one of the listed companies on MTA (Mercato Telematico Azionario) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A. It provides its services to hospitals, private testing laboratories of immunodiagnostics, and molecular diagnostics. It is one of the leading healthcare companies that provide services to about 4000 US hospitals and health systems and approximately 165,000 other providers and healthcare organizations. It provides services at lower costs to hospitals and other pharmaceutical industries.

Company Headquarters: Raritan, New Jersey, US Founded: 1939 Workforce: ~ 5,400 Company Working: Ortho Clinical Diagnostics is a global leader of in-vitro diagnostic services. It provides high-quality products and services to clinical laboratory and immunohematology communities. It provides its services to hospitals, hospital networks, blood banks, and labs in more than 120 countries. It provides testing technologies, automation, information management, and interpretation tools to clinical laboratories around the world.

Company Headquarters: China Founded: 1998 Workforce: ~ 5000 Company Working: Autobio is specialized in the field of clinical, immunological diagnosis. It is one of the leading manufacturers of in-vitro diagnostic reagents and instruments. It operates through different segments such as immunology, microbiology, and biochemistry. It is also actively deployed in the field of molecular detection. Autobio has been listed on the Shanghai Stock Exchange on September 1, 2016. It is the first in-vitro diagnostic manufacturing company listed on the Shanghai Stock Exchange in China. It has established the National Certified Enterprise Technology Center, the National and Local Joint Engineering Laboratory for Immunoassay Automation, and the Henan Province Immunodiagnostic Reagent Engineering Technology Research Center in China.

Company Headquarters: Tokyo, Japan Founded: 1950 Workforce: ~ 500 Company Working: Fujirebio is a global leader in high-quality in-vitro diagnostic (IVD) products. It has 50 years of experience in the conception, development, production, and worldwide commercialization of robust IVD products. It operates through regions such as the US, Latin America, Europe, and Asia. It serves over 80 leading healthcare organizations worldwide. It is one of the worldwide suppliers of high-quality, innovative in-vitro diagnostic (IVD) products. Fujirebio is a part of Miraca Group, a global Japanese healthcare player. It is one of the world leaders in strip-based diagnostic solutions.

Company Headquarters: Shenzhen, Guangdong, China Founded: 1991 Workforce: ~10,000 Company Working: Mindray is one of the leading providers of medical devices and solutions. It mainly operates through segments such as patient monitoring & life support, in-vitro diagnostics, and medical imaging system. It provides healthcare facilities to over 190 countries and regions. It also provides its product to nearly 110,000 medical institutes and also to hospitals.

Incorporated in 1896 and headquarters in Basel, Switzerland; F. Hoffmann-La Roche AG is the world's biggest biotech organization, with genuinely differentiated solutions in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is additionally the world pioneer in vitro diagnostics and tissue-based cancer diagnostics, and a leader in diabetes management. The consolidated qualities of pharmaceuticals and diagnostics under one rooftop have made Roche the pioneer in personalized healthcare. The products offered by the company helps in tapping in the world’s two third of all the diseases which are either not treated effectively or not treated at all. The company offers various products in the Pharmaceutical, Diagnostics and research industry. Geographically the company operates in North America, Europe, South America, Africa, Asia and Oceania. As of 2015 F. Hoffmann-La Roche AG had a head count of 91,700 + employees world wide Roche Strategy – a methodology that intends to fit the right treatment to every patient in the most ideal way that could be available dedicated on developing innovative diagnostic tests and medicines which will help their patients and the world.